Permeation of Nanoparticles into Pulmonary Surfactant Monolayer: In Situ X-ray Standing Wave Studies
Source abstract
Abstract
High-resolution X-ray techniques were applied to examine the effects of gold nanoparticles (size <5 nm) on natural pulmonary surfactant and pure DPPC monolayers preliminarily formed on water subphase in a Langmuir trough. Hydrophobic and hydrophilic nanoparticles were delivered from nanoaerosol using electrodeposition method. Grazing incidence diffraction, X-ray reflectivity, and X-ray standing wave measurements allow to monitor the changes in molecular organization of lipid monolayer and to locate the position of gold nanoparticles. X-ray experiments were performed over a period of 9-14 h. The obtained results evidenced that, on a long time scale, the deposition of nanoparticles, even at low doses, can induce pronounced alterations in lipid monolayer. The presented data can help to elucidate the mechanism of pulmonary translocation of inhaled nanoparticles that is of special interest for biomedical investigations of potential risk of nanoaerosols for human health.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Lipid Membrane Structure and Behavior · Advanced Chemical Sensor Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Research Center Kurchatov Institute, National Research Center Kurchatov Institute, Moscow, 123182 Russia
ESRF─The European Synchron Radiation Facility, 38043 Grenoble, France
Shubnikov Institute of Crystallography, Federal Scientific Research Centre, “Crystallography and Photonics″, Russian Academy of Sciences, Moscow, 119333 Russia
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290 Russia
Funding
Russian Science Foundation
References (53)
Show source-provided references
1. 10.1016/j.bbamem.2008.05.00310.1016/j.bbamem.2008.05.003 ↗
2. 10.1016/S1359-0294(01)00124-810.1016/S1359-0294(01)00124-8 ↗
3. Marconi A. · G. Ital. Med. Lav. Ergon. · 2006 · 28 · 258
4. 10.1289/ehp.733910.1289/ehp.7339 ↗
5. 10.1016/j.jaerosci.2016.05.00510.1016/j.jaerosci.2016.05.005 ↗
6. 10.1080/0278682070120322310.1080/02786820701203223 ↗
7. 10.1016/j.addr.2014.05.01710.1016/j.addr.2014.05.017 ↗
8. 10.1515/ntrev-2016-004710.1515/ntrev-2016-0047 ↗
9. 10.3109/0895837100375881510.3109/08958371003758815 ↗
10. 10.1016/j.bpc.2020.10645710.1016/j.bpc.2020.106457 ↗
11. Willson, D. F.; Chess, P. R.; Wang, Z.; Notter, R. H. The Respiratory Tract in Pediatric Critical Illness and Injury; Springer, 2009; pp 1–14.10.1007/978-1-84800-925-7_10 ↗
12. 10.1096/fasebj.8.12.808846110.1096/fasebj.8.12.8088461 ↗
13. 10.1152/physiol.00006.201010.1152/physiol.00006.2010 ↗
14. 10.1016/j.chemphyslip.2014.09.00210.1016/j.chemphyslip.2014.09.002 ↗
15. 10.1016/j.bbamem.2008.03.02110.1016/j.bbamem.2008.03.021 ↗
16. 10.1021/jp207713x10.1021/jp207713x ↗
17. 10.1021/la502183t10.1021/la502183t ↗
18. 10.3390/coatings1005046910.3390/coatings10050469 ↗
19. 10.1021/la203439u10.1021/la203439u ↗
20. 10.1021/acs.langmuir.7b0107710.1021/acs.langmuir.7b01077 ↗
21. 10.1039/C8EN00189H10.1039/C8EN00189H ↗
22. 10.1016/j.impact.2019.10018610.1016/j.impact.2019.100186 ↗
23. 10.3390/sym1307125910.3390/sym13071259 ↗
24. 10.1021/acs.langmuir.7b0078210.1021/acs.langmuir.7b00782 ↗
25. 10.1134/S106377451802016510.1134/S1063774518020165 ↗
26. 10.1016/j.bbagen.2019.12943510.1016/j.bbagen.2019.129435 ↗
27. 10.1039/C3994000080110.1039/C39940000801 ↗
28. 10.1007/10_2008_4410.1007/10_2008_44 ↗
29. Lanqmuir Trough; available via the Internet at: https://www.esrf.fr/UsersAndScience/Experiments/SoftMatter/ID10/ID10EH1/UsersGuide/exphut/langmuir.
30. 10.1016/S0006-3495(01)76156-510.1016/S0006-3495(01)76156-5 ↗
31. 10.1016/j.bbamem.2012.05.02410.1016/j.bbamem.2012.05.024 ↗
32. 10.1016/S0006-3495(99)77046-310.1016/S0006-3495(99)77046-3 ↗
33. 10.1016/j.bbamem.2011.03.00610.1016/j.bbamem.2011.03.006 ↗
34. 10.3389/fcell.2020.58101610.3389/fcell.2020.581016 ↗
35. 10.1016/j.bpj.2009.06.04010.1016/j.bpj.2009.06.040 ↗
36. 10.1073/pnas.171583011510.1073/pnas.1715830115 ↗
37. 10.1016/j.bpc.2011.06.00110.1016/j.bpc.2011.06.001 ↗
38. 10.1529/biophysj.107.12264810.1529/biophysj.107.122648 ↗
39. 10.1021/bi981386h10.1021/bi981386h ↗
40. 10.1016/j.bpj.2009.08.04510.1016/j.bpj.2009.08.045 ↗
41. 10.1021/acs.langmuir.9b0246910.1021/acs.langmuir.9b02469 ↗
42. 10.1016/S0006-3495(00)76504-010.1016/S0006-3495(00)76504-0 ↗
43. Surfactant BL; available via the Internet at: https://surfactant-bl.com/.
44. Rosenberg, O.; Seiliev, A.; Zhuikov, A. Lung surfactants: Correlation between biophysical characteristics, composition and therapeutic efficacy. Gregoriadis, G., Ed.; Liposome Technology, Informa Healthcare, Taylor&Francis Group, 2006, 3rd ed., Vol. III, Chapter 17; pp 317–346.
45. Rosenberg, O.; Seiliev, A.; Zhuikov, A. Liposome Technology; CRC Press, 2006; pp 343–372.
46. 10.21103/Article8(3)_LE10.21103/Article8(3)_LE ↗
47. 10.1080/0898210060085099710.1080/08982100600850997 ↗
48. 10.1016/j.rmed.2021.10648910.1016/j.rmed.2021.106489 ↗
49. 10.1107/S160057671601044X10.1107/S160057671601044X ↗
50. 10.1039/c1sm05312d10.1039/c1sm05312d ↗
51. Zegenhagen J. · 2013 · 710.1142/6666 ↗
52. 10.1103/PhysRev.95.35910.1103/PhysRev.95.359 ↗
53. 10.1021/la046758410.1021/la0467584 ↗